Literature DB >> 8296484

Killed Campylobacter elicits immune response and protection when administered with an oral adjuvant.

F M Rollwagen1, N D Pacheco, J D Clements, O Pavlovskis, D M Rollins, R I Walker.   

Abstract

The heat-labile toxin (HLT) of enterotoxigenic Escherichia coli (ETEC) is a potent oral adjuvant. We determined whether the ETEC HLT could be mixed with killed campylobacter to induce an immune response protective upon subsequent challenge with live pathogens. Mice were immunized orally three times with 10(9) sonicated campylobacter with or without 25 micrograms of ETEC HLT, and humoral immune responses in intestinal lavage fluids measured by ELISA. Whereas 10(9) live bacteria induced strong intestinal IgA responses, killed bacteria did not unless ETEC HLT was also added. The magnitude of the antibody response was dependent on the amount of antigen given. The ETEC HLT given with bacteria also induced a potent cross-reaction with cholera toxin. The latter had an adjuvant effect in mice similar to that of ETEC HLT. Protection against colonization was studied in mice and rabbits. In contrast to non-immune animals, those given live organisms or sonicated cells mixed with ETEC HLT quickly cleared homologous, but not heterologous, Lior serotypes of Campylobacter upon challenge. These data show for the first time that ETEC HLT can potentiate an immune response to killed campylobacter that promotes a rapid clearance of live pathogens from the intestine.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8296484     DOI: 10.1016/0264-410x(93)90101-3

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  16 in total

1.  Quantitative immunocapture PCR assay for detection of Campylobacter jejuni in foods.

Authors:  D F Waller; S A Ogata
Journal:  Appl Environ Microbiol       Date:  2000-09       Impact factor: 4.792

2.  Restriction fragment length polymorphism of flagellin genes of Campylobacter jejuni and/or C. coli isolates from Egypt.

Authors:  Z S Mohran; P Guerry; H Lior; J R Murphy; A M el-Gendy; M M Mikhail; B A Oyofo
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

3.  Intranasal immunogenicity and adjuvanticity of site-directed mutant derivatives of cholera toxin.

Authors:  G Douce; M Fontana; M Pizza; R Rappuoli; G Dougan
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

4.  Comparison of alternative buffers for use with a new live oral cholera vaccine, Peru-15, in outpatient volunteers.

Authors:  D A Sack; J Shimko; R B Sack; J G Gomes; K MacLeod; D O'Sullivan; D Spriggs
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

5.  C57BL/6 and congenic interleukin-10-deficient mice can serve as models of Campylobacter jejuni colonization and enteritis.

Authors:  L S Mansfield; J A Bell; D L Wilson; A J Murphy; H M Elsheikha; V A K Rathinam; B R Fierro; J E Linz; V B Young
Journal:  Infect Immun       Date:  2006-11-27       Impact factor: 3.441

6.  Murine intranasal challenge model for the study of Campylobacter pathogenesis and immunity.

Authors:  S Baqar; A L Bourgeois; L A Applebee; A S Mourad; M T Kleinosky; Z Mohran; J R Murphy
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

Review 7.  Host-pathogen interactions in Campylobacter infections: the host perspective.

Authors:  Riny Janssen; Karen A Krogfelt; Shaun A Cawthraw; Wilfrid van Pelt; Jaap A Wagenaar; Robert J Owen
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

8.  Immunogenicity and protective efficacy of recombinant Campylobacter jejuni flagellum-secreted proteins in mice.

Authors:  Shahida Baqar; Lisa A Applebee; Theron C Gilliland; Lanfong H Lee; Chad K Porter; Patricia Guerry
Journal:  Infect Immun       Date:  2008-04-21       Impact factor: 3.441

9.  Effect of Campylobacter-specific maternal antibodies on Campylobacter jejuni colonization in young chickens.

Authors:  Orhan Sahin; Naidan Luo; Shouxiong Huang; Qijing Zhang
Journal:  Appl Environ Microbiol       Date:  2003-09       Impact factor: 4.792

10.  Adjuvant activity of a nontoxic mutant of Escherichia coli heat-labile enterotoxin on systemic and mucosal immune responses elicited against a heterologous antigen carried by a live Salmonella enterica serovar Typhimurium vaccine strain.

Authors:  H C Guillobel; J I Carinhanha; L Cárdenas; J D Clements; D F de Almeida; L C Ferreira
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.